FDA warns Curaleaf about inflated claims in CBD product marketing
6 years ago
35
A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is marketing some of its products containing CBD as being effective treatments for cancer, Alzheimer's disease, opioid withdrawal and pain.
Loading comments...
-
1:09
WFTX
2 years agoLighthouse Beach to reopens amid county-wide swim advisory
1.16K -
0:42
KMGH
3 years agoBBB warns about travel scams
62 -
0:43
KMGH
3 years agoBBB warns about counterfeit items
59 -
0:53
KMGH
3 years agoBBB warns about weight loss supplements
15 -
1:14
Reuters
3 years agoWHO warns about Ukraine's 'humanitarian catastrophe'
232 -
0:41
KMGH
3 years agoBBB warns about crypto message on Instagram
40 -
1:58
WFTS
3 years agoFBI warns about popular Facebook scam
83 -
LIVE
The Bubba Army
22 hours agoGOVERNMENT SHUTDOWN! - Bubba the Love Sponge® Show | 10/01/25
2,346 watching -
7:22
Adam Does Movies
19 hours ago $0.51 earnedThe Smashing Machine - Movie Review
7.97K1 -
5:15
Blackstone Griddles
13 hours agoCreamy Cajun Linguine with Bruce Mitchell on the Blackstone Griddle
10.9K1
